Abbreviations: ER = estrogen receptor, HER2= human epidermal growth factor receptor 2, NST = no special type, PR = progesterone receptor, TSR= tumor-stroma ratio Supplementary table 3 . Results of the independent prognostic value of the tumor-stroma ratio adjusted for confounders, triple-negative status and lymph node status calculated with multivariate Cox regression analysis in the ONCOPOOL study.
Recurrence-free survival Overall survival Confounders HR 1.30, 95% CI 0.96 to 1.76, p = 0.085 HR 1.35, 95% CI 1.03 to 1.77, p = 0.029 Confounders including triple-negative status HR 1.30, 95% CI 0.96 to 1.75, p = 0.091 HR 1.34, 95% CI 1.02 to 1.74, p = 0.033 Confounders and lymph node status HR 1.28, 95% CI 0.95 to 1.73, p = 0.112 HR 1.33, 95% CI 1.02 to 1.74, p = 0.037
